DNA読み取り、書き込み、編集の世界市場

DNAの読み取り、書き込み、編集に関する世界市場は、2025年には259億ドルと評価され、2030年までに677億ドルに推定されており、2025年から2030年までの年平均成長率（CAGR）は21.2%に達するとBCC Research では予測しています。

レポートの内容

•  89のデータテーブルと59の追加テーブル
•  DNA読み取り、書き込み、編集技術の世界市場の概要
•  2022年から2024年までの過去の収益データ、2025年の推定値、および2030年の予測を含む、世界市場動向の詳細な分析。この分析には、2030年までの年平均成長率（CAGR）の予測が含まれます。
•  DNA読み取り、書き込み、編集技術に特化した現在の市場規模と収益成長見通しの評価。技術、用途、地域別の市場シェア分析も併せて掲載。
•  世界のDNA読み取り、書き込み、編集技術における現在および将来の需要分析。競争環境、市場規制、償還慣行の詳細な分析も併せて掲載。
•  市場成長に影響を与える要因、課題、機会の分析
•  シーケンス技術、市場用途、業界構造、重要な臨床シーケンスイニシアチブに関する情報
•  進化する技術、現在および将来の市場可能性、研究開発活動、成長戦略、新製品パイプライン、ESG動向に関する考察市場分析
•  主要市場参加企業の市場シェア分析、研究優先事項、製品ポートフォリオ、グローバルランキング、および企業間の競争環境
•  イルミナ社、サーモフィッシャーサイエンティフィック社、キアゲン社、オックスフォード・ナノポア・テクノロジーズ社、BGI社など、業界主要企業の企業プロファイル

Report Highlights

The global market for DNA read, write, and edit was valued at $25.9 billion in 2025 and is estimated to reach $67.7 billion by 2030, at a compound annual growth rate (CAGR) of 21.2% from 2025 through 2030.

Report Includes

• 89 data tables and 59 additional tables
• An overview of the global market for DNA read, write and edit technologies
• In-depth analysis of global market trends, featuring historical revenue data for 2022-2024, estimated figures for 2025, as well as forecasts for 2030. This analysis includes projections of compound annual growth rates (CAGRs) through 2030
• Evaluation of the current market size and revenue growth prospects specific to DNA read, write and edit technologies, accompanied by a market share analysis by technology, application, and region
• Analysis of current and future demand in the global DNA read, write and edit technologies, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
• Analysis of drivers, challenges, and opportunities affecting market growth
• Information on sequencing technologies, market applications, industry structure, and important clinical sequencing initiatives
• A look at the evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, and ESG trends of the market
• Market share analysis of the key market participants, along with their research priorities, product portfolios, global rankings and company competitive landscape
• Company profiles of major players within the industry, including Illumina Inc., Thermo Fisher Scientific Inc., QIAGEN, Oxford Nanopore Technologies plc., and BGI

Report Scope

The scope of the global DNA read, write, and edit market study encompasses market size analysis, as well as a detailed examination of the competitive environment, market dynamics, ongoing research, and driving trends driving market growth. The market has been segmented based on technology, application, and region.

The report provides an overview of the global DNA read, write, and edit market, analyzing market trends. It includes global revenue ($ Million) for the base year 2024 and estimated data for the forecast period 2025 through 2030.

The report covers the total market for DNA read, write, and edit, which includes DNA sequencing, DNA writing, and gene editing. Applications for these products in clinical, research, and other applied areas are also included in the report. The report also focuses on the regional segmentation of the market. The regions covered in this study include North America, Europe, the Asia-Pacific, and the Rest of the World, with a focus on major countries in these regions.

The report focuses on the major driving trends and challenges that affect the market and vendor landscape. It analyzes environmental, social, and corporate governance (ESG) developments and emerging technologies related to the market. It also covers a section on the regulatory landscape of the industry.

The report concludes with an analysis of the competitive landscape and industry structure. It also has a dedicated section of company profiles that covers details of leading companies in the market.

Table of Contents

Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion
Chapter 2 Market Overview
Overview
Sequencing Technologies
Sanger Sequencing
Third-Generation Sequencing
Gene Synthesis Processes
Solid Phase Chemical Synthesis
Genome Editing Technologies
Meganucleases
Zinc Finger Nucleases (ZFNs)
Transcription Activator-like Effector Nucleases (TALENs)
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated Protein 9 (Cas9)
Porter’s Five Forces Analysis in the DNA Read, Write, and Edit Market
Macroeconomic Factor Analysis
U.S. Tariffs
Geopolitical Factors
Increasing Healthcare Expenditures
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Growing Need for Early Detection of Chronic Diseases
Increasing Prevalence of Infectious Diseases
Growing Private Funding for Genome Editing
Market Restraints
Complex and Evolving Regulatory Landscape
High Costs of Sequencing Instruments
Off-Target Impacts of CRISPR Technology
Market Opportunities
Expanding Clinical Applications of Genome Editing
Applications in Plant and Livestock Breeding
Development of Next-Generation CAR-T Therapies
Chapter 4 Regulatory Landscape
Regulatory Paths for Genome Editing
North America
Europe (EU)
Asia-Pacific
Regulatory Landscape Across the Rest of the World
Chapter 5 Emerging Technologies
Key Takeaways
Emerging Technologies
Advances in Sequencing Technologies
In Vivo Delivery of CRISPR
CRISPR-Based Diagnostics
Artificial Intelligence (AI) in DNA Data Analysis
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis by Technology
Key Takeaways
DNA Read (Sequencing)
DNA Write (Synthesis)
DNA Edit (Genome Editing)
Market Analysis by Application
Key Takeaways
Clinical Applications
Research
Applied
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Competitive Intelligence
Key Takeaways
Industry Structure
Competitive Analysis of the DNA Read Market
Strategic Analysis
Funding Outlook
Chapter 8 Sustainability in the DNA Read, Write, and Edit Market: An ESG Perspective
Introduction to ESG
ESG Practices in the DNA Read, Write, and Edit Industry
Environmental Performance
ESG Risk Ratings
Conclusion
Chapter 9 Appendix
Methodology
Sources
Acronyms
Company Profiles
AGILENT TECHNOLOGIES INC.
BEAM THERAPEUTICS
CHARLES RIVER LABORATORIES
EUROFINS GENOMICS
F. HOFFMANN-LA ROCHE LTD.
GENSCRIPT
ILLUMINA INC.
INTEGRATED DNA TECHNOLOGIES INC.
MERCK KGAA
OXFORD NANOPORE TECHNOLOGIES PLC.
PACBIO
QIAGEN
REVVITY
THERMO FISHER SCIENTIFIC INC.
VERTEX PHARMACEUTICALS INC.
Emerging Startups/ Market Disruptors

List of Tables

Summary Table : Global DNA Read, Write, and Edit Market, by Region, Through 2030
Table 1 : DNA Read, Write, and Edit Technology Overview
Table 2 : Asia-Pacific: Regulatory Landscape
Table 3 : RoW: Regulatory Landscape
Table 4 : Global DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 5 : Global DNA Read Market, by Region, Through 2030
Table 6 : Global DNA Read Market, by Product and Service Type, Through 2030
Table 7 : Global DNA Read Consumables Market, by Region, Through 2030
Table 8 : Sequencing Consumables Offered by Major Companies
Table 9 : Global DNA Read Instruments Market, by Region, Through 2030
Table 10 : Sequencing Instruments Offered by Major Companies
Table 11 : Global DNA Read Software and Services Market, by Region, Through 2030
Table 12 : Global DNA Write Market, by Region, Through 2030
Table 13 : Global DNA Write Market, by Type, Through 2030
Table 14 : Global Gene Synthesis Market, by Region, Through 2030
Table 15 : Global Oligonucleotide Synthesis Market, by Region, Through 2030
Table 16 : Global DNA Edit Market, by Region, Through 2030
Table 17 : Global DNA Edit Market, by Editing Technology, Through 2030
Table 18 : Global CRISPR-based DNA Edit Market, by Region, Through 2030
Table 19 : Global TALEN-Based DNA Edit Market, by Region, Through 2030
Table 20 : Global ZFN-Based DNA Edit Market, by Region, Through 2030
Table 21 : Global Meganucleases-Based DNA Edit Market, by Region, Through 2030
Table 22 : Global DNA Read, Write, and Edit Market, by Application, Through 2030
Table 23 : Annual Occurrence Rate of Common Birth Defects in the U.S.
Table 24 : Global DNA Read, Write, and Edit Market for Clinical Applications, by Region, Through 2030
Table 25 : Global DNA Read, Write, and Edit Market for Research Applications, by Region, Through 2030
Table 26 : Global DNA Read, Write, and Edit Market for Applied Applications, by Region, Through 2030
Table 27 : Global DNA Read, Write, and Edit Market, by Region, Through 2030
Table 28 : North American DNA Read, Write, and Edit Market, by Country, Through 2030
Table 29 : North American DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 30 : North American DNA Read Market, by Product and Service Type, Through 2030
Table 31 : North American DNA Write Market, by Type, Through 2030
Table 32 : North American DNA Edit Market, by Editing Technology, Through 2030
Table 33 : North American DNA Read, Write, and Edit Market, by Application, Through 2030
Table 34 : U.S. DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 35 : U.S. DNA Read, Write, and Edit Market, by Application, Through 2030
Table 36 : Canadian DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 37 : Canadian DNA Read, Write, and Edit Market, by Application, Through 2030
Table 38 : Mexican DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 39 : Mexican DNA Read, Write, and Edit Market, by Application, Through 2030
Table 40 : European DNA Read, Write, and Edit Market, by Country, Through 2030
Table 41 : European DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 42 : European DNA Read Market, by Product and Service Type, Through 2030
Table 43 : European DNA Write Market, by Type, Through 2030
Table 44 : European DNA Edit Market, by Editing Technology, Through 2030
Table 45 : European DNA Read, Write, and Edit Market, by Application, Through 2030
Table 46 : German DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 47 : German DNA Read, Write, and Edit Market, by Application, Through 2030
Table 48 : U.K. DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 49 : U.K. DNA Read, Write, and Edit Market, by Application, Through 2030
Table 50 : French DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 51 : French DNA Read, Write, and Edit Market, by Application, Through 2030
Table 52 : Italian DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 53 : Italian DNA Read, Write, and Edit Market, by Application, Through 2030
Table 54 : Spanish DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 55 : Spanish DNA Read, Write, and Edit Market, by Application, Through 2030
Table 56 : Rest of Europe DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 57 : Rest of Europe DNA Read, Write, and Edit Market, by Application, Through 2030
Table 58 : Asia-Pacific DNA Read, Write, and Edit Market, by Country, Through 2030
Table 59 : Asia-Pacific DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 60 : Asia-Pacific DNA Read Market, by Product and Service Type, Through 2030
Table 61 : Asia-Pacific DNA Write Market, by Type, Through 2030
Table 62 : Asia-Pacific DNA Edit Market, by Editing Technology, Through 2030
Table 63 : Asia-Pacific DNA Read, Write, and Edit Market, by Application, Through 2030
Table 64 : Chinese DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 65 : Chinese DNA Read, Write, and Edit Market, by Application, Through 2030
Table 66 : Japanese DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 67 : Japanese DNA Read, Write, and Edit Market, by Application, Through 2030
Table 68 : South Korean DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 69 : South Korean DNA Read, Write, and Edit Market, by Application, Through 2030
Table 70 : Indian DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 71 : Indian DNA Read, Write, and Edit Market, by Application, Through 2030
Table 72 : Australian DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 73 : Australian DNA Read, Write, and Edit Market, by Application, Through 2030
Table 74 : Rest of Asia-Pacific DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 75 : Rest of Asia-Pacific DNA Read, Write, and Edit Market, by Application, Through 2030
Table 76 : RoW DNA Read, Write, and Edit Market, by Sub-region, Through 2030
Table 77 : RoW DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 78 : RoW DNA Read Market, by Product and Service Type, Through 2030
Table 79 : RoW DNA Write Market, by Type, Through 2030
Table 80 : RoW DNA Edit Market, by Editing Technology, Through 2030
Table 81 : RoW DNA Read, Write, and Edit Market, by Application, Through 2030
Table 82 : Competitive Ranking of the DNA Read Market
Table 83 : Recent Developments in the DNA Read, Write, and Edit Market, 2023–2025
Table 84 : Key Investment Deals in the DNA Read, Write, and Edit Industry, 2024 and 2025
Table 85 : Environmental Performance Initiatives in the DNA Read, Write, and Edit Market
Table 86 : Social Performance Initiatives in the DNA Read, Write, and Edit Market
Table 87 : Governance Performance Initiatives in the DNA Read, Write, and Edit Market
Table 88 : ESG Risk Rankings for DNA Read, Write, and Edit Companies, 2025
Table 89 : Report Information Sources
Table 90 : Abbreviations Used in the Global DNA Read, Write, and Edit Market
Table 91 : Agilent Technologies Inc.: Company Snapshot
Table 92 : Agilent Technologies Inc.: Financial Performance, FY 2024 and 2025
Table 93 : Agilent Technologies Inc.: Product Portfolio
Table 94 : Agilent Technologies Inc.: News/Key Developments, 2024 and 2025
Table 95 : Beam Therapeutics: Company Snapshot
Table 96 : Beam Therapeutics: Financial Performance, FY 2023 and 2024
Table 97 : Beam Therapeutics: Product Portfolio
Table 98 : Beam Therapeutics: News/Key Developments, 2023
Table 99 : Charles River Laboratories: Company Snapshot
Table 100 : Charles River Laboratories: Financial Performance, FY 2023 and 2024
Table 101 : Charles River Laboratories: Product Portfolio
Table 102 : Eurofins Genomics: Company Snapshot
Table 103 : Eurofins Genomics: Product Portfolio
Table 104 : Eurofins Genomics: News/Key Developments, 2024
Table 105 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 106 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2023 and 2024
Table 107 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 108 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2023−2025
Table 109 : GenScript: Company Snapshot
Table 110 : GenScript: Financial Performance, FY 2023 and 2024
Table 111 : GenScript: Product Portfolio
Table 112 : GenScript: News/Key Developments, 2024 and 2025
Table 113 : Illumina Inc.: Company Snapshot
Table 114 : Illumina Inc.: Financial Performance, FY 2023 and 2024
Table 115 : Illumina Inc.: Product Portfolio
Table 116 : Illumina Inc.: News/Key Developments, 2025
Table 117 : Integrated DNA Technologies Inc.: Company Snapshot
Table 118 : Integrated DNA Technologies Inc.: Product Portfolio
Table 119 : Integrated DNA Technologies Inc.: News/Key Developments, 2023
Table 120 : Merck KGaA: Company Snapshot
Table 121 : Merck KGaA: Financial Performance, FY 2023 and 2024
Table 122 : Merck KGaA: Product Portfolio
Table 123 : Merck KGaA: News/Key Developments, 2025
Table 124 : Oxford Nanopore Technologies plc.: Company Snapshot
Table 125 : Oxford Nanopore Technologies plc.: Financial Performance, FY 2023 and 2024
Table 126 : Oxford Nanopore Technologies plc.: Product Portfolio
Table 127 : Oxford Nanopore Technologies plc.: News/Key Developments, 2024 and 2025
Table 128 : PacBio: Company Snapshot
Table 129 : PacBio: Financial Performance, FY 2023 and 2024
Table 130 : PacBio: Product Portfolio
Table 131 : PacBio: News/Key Developments, 2025
Table 132 : QIAGEN: Company Snapshot
Table 133 : QIAGEN: Financial Performance, FY 2023 and 2024
Table 134 : QIAGEN: Product Portfolio
Table 135 : QIAGEN: News/Key Developments, 2025
Table 136 : Revvity: Company Snapshot
Table 137 : Revvity: Financial Performance, FY 2023 and 2024
Table 138 : Revvity: Product Portfolio
Table 139 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 140 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 141 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 142 : Thermo Fisher Scientific Inc.: News/Key Developments, 2024
Table 143 : Vertex Pharmaceuticals Inc.: Company Snapshot
Table 144 : Vertex Pharmaceuticals Inc.: Financial Performance, FY 2023 and 2024
Table 145 : Vertex Pharmaceuticals Inc.: Product Portfolio
Table 146 : Vertex Pharmaceuticals Inc.: News/Key Developments, 2023 and 2024
Table 147 : List of a Few Emerging Startups

List of Figures

Summary Figure : Global DNA Read, Write, and Edit Market Shares, by Region, 2024
Figure 1 : Porter’s Five Forces Analysis: DNA Read, Write, and Edit Market
Figure 2 : Market Dynamics of Global DNA Read, Write, and Edit
Figure 3 : Emerging Technologies in the DNA Read, Write, and Edit Market
Figure 4 : Global DNA Read, Write, and Edit Market Shares, by Technology, 2024
Figure 5 : Global DNA Read Market Shares, by Product and Service Type, 2024
Figure 6 : Global DNA Write Market Shares, by Type, 2024
Figure 7 : Global DNA Edit Market Shares, by Editing Technology, 2024
Figure 8 : Global DNA Read, Write, and Edit Market Shares, by Application, 2024
Figure 9 : Global DNA Read, Write, and Edit Market Shares, by Region, 2024
Figure 10 : North American DNA Read, Write, and Edit Market Shares, by Country, 2024
Figure 11 : European DNA Read, Write, and Edit Market Shares, by Country, 2024
Figure 12 : Asia-Pacific DNA Read, Write, and Edit Market Shares, by Country, 2024
Figure 13 : RoW DNA Read, Write, and Edit Market Shares, by Sub-region, 2024
Figure 14 : Key ESG Metrics of DNA Read, Write, and Edit Companies
Figure 15 : Agilent Technologies Inc.: Revenue Shares, by Business Unit, FY 2025
Figure 16 : Agilent Technologies Inc.: Revenue Shares, by Country/Region, FY 2025
Figure 17 : Charles River Laboratories: Revenue Shares, by Business Unit, FY 2024
Figure 18 : Charles River Laboratories: Revenue Shares, by Country/Region, FY 2024
Figure 19 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Business Unit, FY 2024
Figure 20 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Country/Region, FY 2024
Figure 21 : GENSCRIPT: Revenue Shares, by Business Unit, FY 2024
Figure 22 : GENSCRIPT: Revenue Shares, by Country/Region, FY 2024
Figure 23 : Illumina Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 24 : Merck KGaA: Revenue Shares, by Business Unit, FY 2024
Figure 25 : Merck KGaA: Revenue Shares, by Country/Region, FY 2024
Figure 26 : Oxford Nanopore Technologies plc.: Revenue Shares, by Country/Region, FY 2024
Figure 27 : PACBIO: Revenue Shares, by Country/Region, FY 2024
Figure 28 : QIAGEN: Revenue Shares, by Business Unit, FY 2024
Figure 29 : QIAGEN: Revenue Shares, by Country/Region, FY 2024
Figure 30 : Revvity: Revenue Shares, by Business Unit, FY 2024
Figure 31 : Revvity: Revenue Shares, by Country/Region, FY 2024
Figure 32 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 33 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 34 : Vertex Pharmaceuticals Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 35 : Vertex Pharmaceuticals Inc.: Revenue Shares, by Country/Region, FY 2024